Redmond, WA, United States of America

Inventprise, LLC

USPTO Granted Patents = 26

Trademarks = 2

Forward Citations = 32

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Subhash V Kapre (26 out of 27 patents)

silverMedal Anup K Datta (10 out of 11 patents)

bronzeMedal Kapil Subhash Kapre (3 out of 3 patents)

4.  Ivan A Olave (2 out of 2 patents)

5.  Francis Michon (2 out of 31 patents)

6.  Kapil S Kapre (1 out of 1 patent)


Core Competencies:
Pneumococcal Vaccines
Glycoconjugate Vaccines
Virus-Like Particles
Immunogenic Compositions
Bioprocess Systems
Polysaccharide Purification
Heat Stable Vaccines
Bordetella Pertussis
Multivalent Conjugates
Pegylated Compounds

26 patents:

Company Overview
Inventprise, LLC, based in Redmond, WA, specializes in the development of innovative solutions in the field of medical technology. The company focuses on creating advanced therapeutic devices and systems aimed at improving patient outcomes and enhancing healthcare delivery. With a commitment to research and development, Inventprise leverages cutting-edge technology to address unmet medical needs, positioning itself as a key player in the healthcare innovation landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Inventprise, LLC USPTO Patent Assignee Logo
26 Patents

#31 in Redmond, WA

#289 in Washington

#12,865 in US

#24,826 in the World

Redmond, WA (US)
Redmond, WA, United States of America
Forward Citations = 32

6 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inventprise, LLC. Retrieved from https://idiyas.com/company/inventprise

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…